219 related articles for article (PubMed ID: 21955009)
1. Voriconazole-induced QT interval prolongation and torsades de pointes.
Aypar E; Kendirli T; Tutar E; Çiftçi E; Ince E; Ileri T; Atalay S
Pediatr Int; 2011 Oct; 53(5):761-763. PubMed ID: 21955009
[No Abstract] [Full Text] [Related]
2. OTc prolongation and torsade de pointes ventricular tachycardia in a small dose voriconazole therapy.
Elbey MA; Cil H; Onturk E; Islamoglu Y
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):100-2. PubMed ID: 22338554
[TBL] [Abstract][Full Text] [Related]
3. Inherited long QT syndrome revealed by antifungals drug-drug interaction.
Eiden C; Peyrière H; Tichit R; Cociglio M; Amedro P; Blayac JP; Margueritte G; Hillaire-Buys D
J Clin Pharm Ther; 2007 Jun; 32(3):321-4. PubMed ID: 17489884
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect.
Alkan Y; Haefeli WE; Burhenne J; Stein J; Yaniv I; Shalit I
Clin Infect Dis; 2004 Sep; 39(6):e49-52. PubMed ID: 15472801
[TBL] [Abstract][Full Text] [Related]
5. Torsades de pointes associated with voriconazole use.
Philips JA; Marty FM; Stone RM; Koplan BA; Katz JT; Baden LR
Transpl Infect Dis; 2007 Mar; 9(1):33-6. PubMed ID: 17313469
[TBL] [Abstract][Full Text] [Related]
6. Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline.
Dorsey ST; Biblo LA
Am J Emerg Med; 2000 Mar; 18(2):227-9. PubMed ID: 10750939
[No Abstract] [Full Text] [Related]
7. Effect of combined fluoroquinolone and azole use on QT prolongation in hematology patients.
Zeuli JD; Wilson JW; Estes LL
Antimicrob Agents Chemother; 2013 Mar; 57(3):1121-7. PubMed ID: 23229485
[TBL] [Abstract][Full Text] [Related]
8. Fluconazole-associated QT interval prolongation and Torsades de Pointes in a paediatric patient.
Ünal Yüksekgönül A; Ertuğrul İ; Karagöz T
Cardiol Young; 2021 Dec; 31(12):2035-2037. PubMed ID: 34024302
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced prolongation of the QT interval.
Curigliano G; Cipolla C; de Braud F
N Engl J Med; 2004 Jun; 350(25):2618-21; author reply 2618-21. PubMed ID: 15208787
[No Abstract] [Full Text] [Related]
10. Prolonged QT interval and torsades de pointes associated with atazanavir therapy.
Ly T; Ruiz ME
Clin Infect Dis; 2007 Mar; 44(6):e67-8. PubMed ID: 17304444
[TBL] [Abstract][Full Text] [Related]
11. Optimal location of the QT interval evaluation in patients with drug-induced QT prolongation and torsades de pointes: Limb leads, chest leads, or both?
Lakkis B; Refaat MM
J Cardiovasc Electrophysiol; 2020 Oct; 31(10):2702-2703. PubMed ID: 32700425
[No Abstract] [Full Text] [Related]
12. Serious QT interval prolongation with ranolazine and amiodarone.
Tarapués M; Cereza G; Arellano AL; Montané E; Figueras A
Int J Cardiol; 2014 Mar; 172(1):e60-1. PubMed ID: 24424337
[No Abstract] [Full Text] [Related]
13. Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System（FAERS）.
Yu Z; Liao X
J Pharm Pharm Sci; 2022; 25():237-243. PubMed ID: 35790147
[TBL] [Abstract][Full Text] [Related]
14. QT interval prolongation and torsade de pointes associated with indapamide. Comments to Letsas et al.
Perciaccante A; Fiorentini A
Int J Cardiol; 2007 Nov; 122(3):255; author reply 256-7. PubMed ID: 17368589
[No Abstract] [Full Text] [Related]
15. [Long QT syndrome due to olanzapine administration].
Janion M; Dudek A; Sielski J; Janion-Sadowska A
Kardiol Pol; 2006 Sep; 64(9):986-8. PubMed ID: 17054030
[TBL] [Abstract][Full Text] [Related]
16. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
Mok NS; Lo YK; Tsui PT; Lam CW
J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
[TBL] [Abstract][Full Text] [Related]
17. Abiraterone acetate-associated QT prolongation and torsades de pointes: Postmarketing cases reported to FDA.
McBride L; Woronow D; Nayernama A; Christopher Jones S
J Oncol Pharm Pract; 2021 Jul; 27(5):1315-1316. PubMed ID: 33990160
[No Abstract] [Full Text] [Related]
18. Torsades de pointes complicating complete heart block with QT interval prolongation.
Stankovic I; Putnikovic B; Neskovic AN
Acta Cardiol; 2016; 71(5):627. PubMed ID: 27695027
[No Abstract] [Full Text] [Related]
19. Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: use of drug levels in diagnosis.
Link MS; Foote CB; Sloan SB; Homoud MK; Wang PJ; Estes NA
Chest; 1997 Aug; 112(2):556-7. PubMed ID: 9266902
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial-associated QT interval prolongation: pointes of interest.
Owens RC; Nolin TD
Clin Infect Dis; 2006 Dec; 43(12):1603-11. PubMed ID: 17109296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
